JPS57131725A - Remedy for immune complex disease - Google Patents

Remedy for immune complex disease

Info

Publication number
JPS57131725A
JPS57131725A JP56018429A JP1842981A JPS57131725A JP S57131725 A JPS57131725 A JP S57131725A JP 56018429 A JP56018429 A JP 56018429A JP 1842981 A JP1842981 A JP 1842981A JP S57131725 A JPS57131725 A JP S57131725A
Authority
JP
Japan
Prior art keywords
acid
remedy
human urine
acid protease
buffer solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56018429A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6237611B2 (enrdf_load_stackoverflow
Inventor
Haruo Onishi
Koji Kojiyaku
Yasuo Suzuki
Suguru Mochida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Priority to JP56018429A priority Critical patent/JPS57131725A/ja
Priority to CA000395742A priority patent/CA1181005A/en
Priority to CH782/82A priority patent/CH653557A5/de
Priority to AU80290/82A priority patent/AU531314B2/en
Priority to SE8200748A priority patent/SE455163B/sv
Priority to GB8203682A priority patent/GB2095993B/en
Priority to IT47761/82A priority patent/IT1154280B/it
Priority to DE19823204631 priority patent/DE3204631A1/de
Priority to FR8202145A priority patent/FR2499409A1/fr
Priority to NL8200509A priority patent/NL8200509A/nl
Priority to EP82100973A priority patent/EP0059346B1/en
Priority to DE8282100973T priority patent/DE3273953D1/de
Priority to US06/365,465 priority patent/US4540569A/en
Publication of JPS57131725A publication Critical patent/JPS57131725A/ja
Publication of JPS6237611B2 publication Critical patent/JPS6237611B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP56018429A 1981-02-10 1981-02-10 Remedy for immune complex disease Granted JPS57131725A (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
JP56018429A JPS57131725A (en) 1981-02-10 1981-02-10 Remedy for immune complex disease
CA000395742A CA1181005A (en) 1981-02-10 1982-02-08 Therapeutic agent for treatment of allergic diseases, immune complex diseases and tumors
CH782/82A CH653557A5 (de) 1981-02-10 1982-02-09 Zur behandlung von allergischen zustaenden, immunkomplexkrankheiten und tumoren geeignetes therapeutisches mittel.
AU80290/82A AU531314B2 (en) 1981-02-10 1982-02-09 Therapeutic agent containing human urinary acid protease
SE8200748A SE455163B (sv) 1981-02-10 1982-02-09 Uropepsin for anvendning som terapeutikum mot allergiska sjukdomar, immunkomplexsjukdomar och tumorer
GB8203682A GB2095993B (en) 1981-02-10 1982-02-09 Compositions containing human urinary acid protease
IT47761/82A IT1154280B (it) 1981-02-10 1982-02-10 Agente terapeutico a base di protea si acida e suo impiego in pazienti affetti da disordini allergici,malattie da immuno-complessi e tumori
DE19823204631 DE3204631A1 (de) 1981-02-10 1982-02-10 Therapeutisches mittel und dessen verwendung
FR8202145A FR2499409A1 (fr) 1981-02-10 1982-02-10 Agent therapeutique a base d'une protease acide, pour le traitement des troubles allergiques, des maladies avec immunocomplexe et des tumeurs
NL8200509A NL8200509A (nl) 1981-02-10 1982-02-10 Geneesmiddel voor allergiekwalen, immuuncomplexziekten en tumoren; werkwijze voor het behandelen van patienten die hieraan lijden.
EP82100973A EP0059346B1 (en) 1981-02-10 1982-02-10 Therapeutic agent containing a human urinary pepsin
DE8282100973T DE3273953D1 (en) 1981-02-10 1982-02-10 Therapeutic agent containing a human urinary pepsin
US06/365,465 US4540569A (en) 1981-02-10 1982-04-05 Method for treatment of allergic disorders and immune complex diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56018429A JPS57131725A (en) 1981-02-10 1981-02-10 Remedy for immune complex disease

Publications (2)

Publication Number Publication Date
JPS57131725A true JPS57131725A (en) 1982-08-14
JPS6237611B2 JPS6237611B2 (enrdf_load_stackoverflow) 1987-08-13

Family

ID=11971396

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56018429A Granted JPS57131725A (en) 1981-02-10 1981-02-10 Remedy for immune complex disease

Country Status (1)

Country Link
JP (1) JPS57131725A (enrdf_load_stackoverflow)

Also Published As

Publication number Publication date
JPS6237611B2 (enrdf_load_stackoverflow) 1987-08-13

Similar Documents

Publication Publication Date Title
Brade et al. Ifosfamide-pharmacology, safety and therapeutic potential
GR76810B (enrdf_load_stackoverflow)
EG19642A (en) A process for the preparation of oral composition for the treatment of inflammatory bowel diseases
JPS5756427A (en) Medicine containing 2-phenyl-1,2-benzisoselenazole- 3(2h)-one
DK452289D0 (da) Praeparat eller system til behandling af diabetes
Gray et al. Protective effect of pitressin and epinephrine against total body X-irradiation
DE3279946D1 (en) Rectally administrable suppository comprising a drug and an adjuvant
ES8504459A1 (es) Procedimiento para preparar factor de transferencia especifico a un virus determinado.
JPS57131725A (en) Remedy for immune complex disease
JPS56138111A (en) Suppository containing unsaturated fatty acid or salt thereof
GB2092001B (en) Pharmaceutical preparations comprising sodium fructose-1,6-diphosposphate for treatment of burn patients
BG96324A (bg) Фармакологично активно вещество врс, метод за неговото получаване и терапевтичното му приложение
Hamaoka et al. Antibody production in mice: II. The mechanism of antigenic stimulation in the secondary immune response
JPS56138110A (en) Suppository containing citric acid or salt thereof
IE44814L (en) Treatment of gastroenteritis.
JPS5793913A (en) Enhancing agent for spermous vital power
JPS56138112A (en) Suppository containing ascorbic acid or sodium ascorbate
JPS55113721A (en) Immunity regulator
DE3568944D1 (en) Pharmaceutical composition for oral administration containing, on the one hand, as active principle the 9-alpha,11-beta dichloro-16-alpha methyl 21-oxycarbonyldicyclohexylmethyloxy pregna-1,4-diene 3,20-dione and, on the other hand, an inert pharmaceutical excipient which is able to permit the activity of the product in the rectum or in the colon and the utilization of the active principle in the preparation of such a pharmaceutical composition
JPS5543041A (en) Immunity raising agent
JPS56138115A (en) Suppository containing acidic amino acid or derivative thereof
JPS5522641A (en) Antiallergic agent
Drozdovskiĭ et al. Radiosynoviorthese in the treatment of patients with rheumatoid arthritis
JPS5629525A (en) Preventive and remedy for infectious disease in intestine
Rojas et al. Treatment of chronic amebiasis in pediatric patients with a suspension of quinfamide